相关实验视频
Updated: May 11, 2026
14:49
Self-reporting Scaffolds for 3-Dimensional Cell Culture
Published on: November 7, 2013
13.1K
监督机器学习用于预测从乙化德克斯纳米纤维中释放的药物.
Ryan N Woodring1, Elizabeth G Gurysh1, Tanvi Pulipaka1
1Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at, Chapel Hill, USA. ainsliek@email.unc.edu.
Biomaterials science
|April 16, 2025
概括
这项研究引入了一种机器学习模型,用于预测从乙化德克斯 (Ace-DEX) 纳米纤维中释放的药物. 这种方法简化了体外试验,加速了先进药物输送系统的开发.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 计算生物学 计算生物学
背景情况:
- 电纳米纤维提供增强的药物生物可用性和有针对性的输送.
- 乙甲 (Ace-DEX) 是一种生物相容的聚合物,可控制药物释放.
- 目前的体外药物释放特征是劳动密集型的,限制了临床翻译.
研究的目的:
- 开发一种新的机器学习工作流程,用于评估Ace-DEX纳米纤维的体外药物释放.
- 创建一个预测模型,简化药物释放动态的表征.
- 建立一种药物不可知的方法来预测随着时间的推移释放的药物分量.
主要方法:
- 开发和应用高斯过程回归 (GPR) 模型.
- 使用30个电Ace-DEX支架的体外释放数据来训练,验证和优化GPR模型.
- 在各种Ace-DEX配方中评估模型性能.
主要成果:
- 开发的GPR模型准确地预测了Ace-DEX纳米纤维的体外药物释放.
- 该模型在所有测试的Ace-DEX配方中显示出一致的性能.
- 预测方法被证明是药物不可知,适用于不同的治疗剂.
结论:
- 机器学习,特别是GPR,提供了一种高效可靠的方法来表征从电纳米纤维释放的药物.
- 这种新的工作流显著减少了与体外药物释放研究相关的劳动力.
- 药物不可知性预测模型加速了用于临床应用的电药物递送系统的翻译.
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...